Microbank Crystal is pleased to announce the successful completion of a new funding agreement with Symbiotics, a long-standing and trusted partner in inclusive and sustainable finance.
The transaction amounts to USD 5 million in senior debt, sourced from several funds managed by Symbiotics. The financing is denominated in Georgian Lari, ensuring that resources are closely aligned with the needs of local clients.
The proceeds will be directed toward supporting micro, small, and medium enterprises (MSMEs), as well as low and middle-income households across Georgia, empowering them to grow and thrive.
Crystal and Symbiotics have built a strong and enduring partnership over the years. This latest transaction not only deepens that collaboration but also reaffirms our shared commitment to advancing financial inclusion and sustainable development in Georgia.
“We are pleased to strengthen our partnership with Symbiotics through this new transaction, which reinforces Crystal’s funding base and enables us to continue growing responsibly while creating long-term value for our stakeholders” – said Ilia Revia, CEO of Crystal.
“This new facility is part of our long-lasting partnership with Crystal, it witnesses the investors’ continued interest in supporting micro and SME business clients in Georgia. We are looking forward to maintaining and further building foreign direct investments in the region.” – commented Alexandr Fando, Regional Manager for Caucasus and Central Asia at Symbiotics Investments.
About Microbank Crystal
Founded in Georgia, Crystal is recognized as one of the country’s leading financial institutions, known for its sustained growth and robust reputation. On February 12, 2025, the company officially received its microbank license from the National Bank of Georgia. With 27 years of experience, a loan portfolio of over 570 million GEL, a team of more than 1,000 employees across 48 branches, and a client base exceeding 100,000 individuals nationwide, Crystal continues to be a key player in Georgia’s financial landscape. The company maintains strategic partnerships with major international and local financial institutions.
About Symbiotics
Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies. The group offers investment, asset management and capacity building services. Since 2005, we have originated over 8,200 investments representing more than USD 10.5 billion for 608 companies in 99 countries. We manage an aggregate portfolio of USD 2.5 billion spread across 19 funds and mandates. Our portfolio companies have also benefited from over 170 technical assistance projects worth more than USD 19 million.